Josefina Cernadas

2.4k total citations · 1 hit paper
36 papers, 1.2k citations indexed

About

Josefina Cernadas is a scholar working on Pharmacology, Dermatology and Immunology and Allergy. According to data from OpenAlex, Josefina Cernadas has authored 36 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pharmacology, 17 papers in Dermatology and 12 papers in Immunology and Allergy. Recurrent topics in Josefina Cernadas's work include Drug-Induced Adverse Reactions (34 papers), Contact Dermatitis and Allergies (13 papers) and Food Allergy and Anaphylaxis Research (10 papers). Josefina Cernadas is often cited by papers focused on Drug-Induced Adverse Reactions (34 papers), Contact Dermatitis and Allergies (13 papers) and Food Allergy and Anaphylaxis Research (10 papers). Josefina Cernadas collaborates with scholars based in Portugal, Italy and Spain. Josefina Cernadas's co-authors include Knut Brockow, Antonino Romano, Marı́a José Torres, Sevim Bavbek, Anca Mirela Chiriac, Pascal Demoly, Eva Gómes, Gülfem Çelík, Jean‐Christoph Caubet and Patrizia Bonadonna and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Allergy and Annals of Allergy Asthma & Immunology.

In The Last Decade

Josefina Cernadas

32 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti‐inflammatory drugs

2013 330 citations Sevim Bavbek, Knut Brockow et al. Allergy profile →

Peers

Josefina Cernadas

PHARM

IA

DERMA

PHYSI

RHEUM

Anca Mirela Chiriac France

Carlos Fernández Vidaurre United States

Noritaka Higashi Japan

Adam Ćmiel Poland

Harriet Hédin Sweden

N. Freymond France

Atkins Rc Australia

Jur Strobos United States

M F Shadforth United Kingdom

K A Grindulis United Kingdom

Anca Mirela Chiriac France

Josefina Cernadas

992 ×1.0

PHARM

586 ×1.4

IA

531 ×1.3

DERMA

259 ×0.8

PHYSI

206 ×0.7

RHEUM

Citations per year, relative to Josefina Cernadas Josefina Cernadas (= 1×) peers Anca Mirela Chiriac

Countries citing papers authored by Josefina Cernadas

Since Specialization

Citations

This map shows the geographic impact of Josefina Cernadas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josefina Cernadas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josefina Cernadas more than expected).

Fields of papers citing papers by Josefina Cernadas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josefina Cernadas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josefina Cernadas. The network helps show where Josefina Cernadas may publish in the future.

Co-authorship network of co-authors of Josefina Cernadas

This figure shows the co-authorship network connecting the top 25 collaborators of Josefina Cernadas. A scholar is included among the top collaborators of Josefina Cernadas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josefina Cernadas. Josefina Cernadas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Cernadas, Josefina, et al.. (2024). Multiple drug hypersensitivity syndrome manifesting as acute generalised exanthematous pustulosis: A rare case report. Contact Dermatitis. 90(4). 439–441.

2.

Cernadas, Josefina, et al.. (2023). Desensitization in children allergic to drugs: Indications, protocols, and limits. Pediatric Allergy and Immunology. 34(6). e13965–e13965. 3 indexed citations

3.

Barbaud, A., Lene H. Garvey, Marı́a José Torres, et al.. (2023). EAACI/ENDA position paper on drug provocation testing. Allergy. 79(3). 565–579. 58 indexed citations

4.

Cernadas, Josefina, et al.. (2023). Exfoliative Dermatitis During Antituberculosis Treatment. The Journal of Allergy and Clinical Immunology In Practice. 12(2). 495–496.

5.

Cernadas, Josefina, et al.. (2021). Desensitization to carboplatin in low‐grade glioma. A revision of 100 treatments in children. Pediatric Allergy and Immunology. 32(6). 1388–1391. 5 indexed citations

6.

Rama, Tiago Azenha, Diana Silva, & Josefina Cernadas. (2021). Biphasic Blue Urticaria. The Journal of Allergy and Clinical Immunology In Practice. 9(6). 2474–2475. 1 indexed citations

7.

Oussalah, Abderrahim, Vincent Yip, Cristobalina Mayorga, et al.. (2020). Genetic variants associated with T cell–mediated cutaneous adverse drug reactions: A PRISMA‐compliant systematic review—An EAACI position paper. Allergy. 75(5). 1069–1098. 14 indexed citations

8.

Torres, Marı́a José, Axel Trautmann, Ingrid Böhm, et al.. (2020). Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity. Allergy. 76(5). 1325–1339. 84 indexed citations

9.

Cernadas, Josefina, et al.. (2020). Caso de reação de hipersensibilidade a fármaco de emergência médica – Novo protocolo de dessensibilização. Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT). 28(3).

10.

Torres, Marı́a José, Gülfem Çelík, Paul Whitaker, et al.. (2019). A EAACI drug allergy interest group survey on how European allergy specialists deal with β‐lactam allergy. Allergy. 74(6). 1052–1062. 39 indexed citations

11.

Romano, Antonino, Marina Atanasković‐Marković, A. Barbaud, et al.. (2019). Towards a more precise diagnosis of hypersensitivity to beta‐lactams — an EAACI position paper. Allergy. 75(6). 1300–1315. 194 indexed citations

12.

Cernadas, Josefina, et al.. (2019). Acute Generalized Exanthematous Pustulosis Due to Clavulanic Acid. The Journal of Allergy and Clinical Immunology In Practice. 8(3). 1083–1084. 6 indexed citations

13.

Costa, María José, María Teresa Herdeiro, Jorge Polónia, et al.. (2018). Type B adverse drug reactions reported by an immunoallergology department. Pharmacy Practice. 16(1). 1070–1070. 3 indexed citations

14.

Castro, Eunice Dias de, et al.. (2018). Overview of Drug Allergy: From Immunogenetic Basis to Practice. Acta Médica Portuguesa. 31(10). 581–588. 2 indexed citations

15.

Sánchez‐Borges, Mario, Werner Aberer, Knut Brockow, et al.. (2018). Controversies in Drug Allergy: Radiographic Contrast Media. The Journal of Allergy and Clinical Immunology In Practice. 7(1). 61–65. 71 indexed citations

16.

Cernadas, Josefina. (2017). Reactions to cytostatic agents in children. Current Opinion in Allergy and Clinical Immunology. 17(4). 255–261. 8 indexed citations

17.

Castro, Eunice Dias de, et al.. (2015). Anaphylaxis to selective COX‐2 inhibitors: an unexpected culprit. Clinical and Translational Allergy. 5(S3).

18.

Cernadas, Josefina. (2012). Desensitization to antibiotics in children. Pediatric Allergy and Immunology. 24(1). 3–9. 24 indexed citations

19.

Pagani, Mauro, et al.. (2012). An Experimental Biological Test to Diagnose Hypersensitivity Reactions to Carboplatin: New Horizons for an Old Problem. Japanese Journal of Clinical Oncology. 42(4). 347–350. 19 indexed citations

20.

Demoly, Pascal, Antonino Romano, L. Bousquet‐Rouanet, et al.. (2009). Determining the negative predictive value of provocation tests with beta‐lactams. Allergy. 65(3). 327–332. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact